Cardiology 2013

Notes: Alsafi, A

Kaya, G

Patel, H

Hamady, M S

eng

Comparative Study

India

2013/03/26 06:00

J Postgrad Med. 2013 Jan-Mar;59(1):69-75. doi: 10.4103/0022-3859.109509.

URL: http://www.ncbi.nlm.nih.gov/pubmed/23525067

Author Address: Department of Interventional Radiology, Imperial College, St. Mary’s Hospital, Praed Street, London W2 1NY, United Kingdom.

 

 

Reference Type:  Journal Article

Record Number: 531Author: Alzueta, J. and Fernandez, J. M.

Year: 2013

Title: Spanish Implantable Cardioverter-defibrillator Registry. Ninth Official Report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2012)

Journal: Rev Esp Cardiol

Volume: 66

Issue: 11

Pages: 881-893

Date: Nov

Short Title: Spanish Implantable Cardioverter-defibrillator Registry. Ninth Official Report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2012)

Alternate Journal: Revista espanola de cardiologia

ISSN: 1579-2242 (Electronic)

0300-8932 (Linking)

DOI: 10.1016/j.recesp.2013.07.003

Original Publication: Registro Espanol de Desfibrilador Automatico Implantable. IX Informe Oficial de la Seccion de Electrofisiologia y Arritmias de la Sociedad Espanola de Cardiologia (2012).

Accession Number: 24063772

Abstract: INTRODUCTION AND OBJECTIVES: To summarize the findings of the Spanish Implantable Cardioverter-defibrillator Registry for 2012 compiled by the Electrophysiology and Arrhythmias Section of the Spanish Society of Cardiology. METHODS: Prospective data recorded voluntarily on single-page questionnaires were sent to the Spanish Society of Cardiology by each implantation team. RESULTS: Overall, 4216 device implantations were reported, representing 80.8% of the estimated total number of implantations. The reported implantation rate was 91.2 per million population and the estimated total implantation rate was 113 per million. The proportion of first implantations was 69.4%. We collected data from 161 hospitals (6 fewer than in 2011). The majority of implantable cardioverter-defibrillator recipients were men (83.4%). Mean age was 61.8 (13.4) years. Most patients had severe or moderate-to-severe ventricular dysfunction and were in New York Heart Association functional class II. Ischemic heart disease was the most frequent underlying cardiac condition, followed by dilated cardiomyopathy. The number of indications for primary prevention decreased over the previous year and now account for 58.1% of first implantations. Overall, 81% of the implantable cardioverter-defibrillator were implanted by cardiac electrophysiologists. CONCLUSIONS: The 2012 Spanish Implantable Cardioverter-defibrillator Registry includes data on 80.8% of all implantable cardioverter-defibrillators implantations performed in Spain. This is the second consecutive year in which the number of implantations has slightly decreased compared to the previous year. This year, the percentage of implantations for primary prevention indications also decreased. Full English text available from:www.revespcardiol.org/en.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208